MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program

Go back to MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
MACROGENICS (NASDAQ: MGNX) Delayed: 4.34 -0.06 (1.36%)
Previous Close $4.40    52 Week High $36.11 
Open $4.29    52 Week Low $14.84 
Day High $4.43    P/E 11.13 
Day Low $4.11    EPS $0.39 
Volume 159,290